A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs

Biomaterials

Volumn 30, Issue 11, 2009, Pages 2102-2111

  Chen, Mei Chin ^a   Tsai, Hung Wen ^b   Liu, Chin Tang ^a   Peng, Shu Fen ^a   Lai, Wei Yun ^a   Chen, Shiang Jiuun ^c   Chang, Yen ^b   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Chitosan; Drug delivery; Drug eluting stent; Hydrogel; Micelle

Indexed keywords

ABDOMINAL AORTAS; BURST RELEASE; CROSSLINKED; DRUG RELEASE; DRUG-DELIVERY SYSTEMS; DRUG-ELUTING STENT; EPOXY COMPOUNDS; HYDROGEL; HYDROPHOBIC CORES; IN-STENT RESTENOSIS; INFLAMMATORY REACTIONS; LIPOPHILIC DRUGS; LOADING EFFICIENCIES; MICELLE; NANO-SCALE; PLURONIC; POORLY SOLUBLE DRUGS; SIROLIMUS; THERAPEUTIC AGENTS;

AMINES; ARTIFICIAL ORGANS; CHITIN; CHITOSAN; COLLOIDS; DRUG DELIVERY; ETHERS; MICELLES; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

HYDROGELS;

CHITOSAN; EPOXIDE; POLOXAMER; RAPAMYCIN;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG RELEASE; DRUG RETENTION; DRUG SOLUBILITY; HYDROGEL; IN-STENT RESTENOSIS; INFLAMMATION; LIPOPHILICITY; MICELLE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; HYDROGEL; IMMUNOSUPPRESSIVE AGENTS; MICELLES; RABBITS; RATS;

ORYCTOLAGUS CUNICULUS;

EID: 60049096094     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.12.047     Document Type: Article

References (34)

1. Lin C.C., and Metters A.T. Hydrogels in controlled release formulations: network design and mathematical modelling. Adv Drug Deliv Rev 58 (2006) 1379-1408
2. Bae K.H., Mok H., and Park T.G. Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death. Biomaterials 29 (2008) 3376-3383
3. Chun K.W., Lee J.B., Kim S.H., and Park T.G. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogel. Biomaterials 26 (2005) 3319-3326
4. Kashyap N., Viswanad B., Sharma G., Bhardwaj V., Ramarao P., and Ravi Kumar M.N. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials 28 (2007) 2051-2060
5. Huynh D.P., Nguyen M.K., Pi B.S., Kim M.S., Chae S.Y., Lee K.C., et al. Functionalized injectable hydrogels for controlled insulin delivery. Biomaterials 29 (2008) 2527-2534
6. Casolaro M., Paccagnini E., Mendichi R., and Ito Y. Stimuli-responsive polymers based on l-phenylalanine residues: protonation thermodynamics of free polymers and cross-linked hydrogels. Macromolecules 38 (2005) 2460-2468
7. Yoshida R., Omata K., Yamaura K., Ebata M., Tanaka M., and Takai M. Maskless microfabrication of thermosensitive gels using a microscope and application to a controlled release microchip. Lab Chip 6 (2006) 1384-1386
8. Yoshida R., Takahashi T., Yamaguchi T., and Ichijo H. Self-oscillating gels. Adv Mater 9 (1997) 175-178
9. Wu J., Wei W., Wang L.Y., Su Z.G., and Ma G.H. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials 28 (2007) 2220-2232
10. Mabilleau G., Aguado E., Stancu I.C., Cincu C., Baslé M.F., and Chappard D. Effects of FGF-2 release from a hydrogel polymer on bone mass and microarchitecture. Biomaterials 29 (2008) 1593-1600
11. Torchilin V.P. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 61 (2004) 2549-2559
12. Chen M.C., Tsai H.W., Chang Y., Lai W.Y., Mi F.L., Liu C.T., et al. Rapidly self-expandable polymeric stents with a shape-memory property. Biomacromolecules 8 (2007) 2774-2780
13. Kretsinger J.K., Haines L.A., Ozbas B., Pochan D.J., and Schneider J.P. Cytocompatibility of self-assembled beta-hairpin peptide hydrogel surfaces. Biomaterials 26 (2005) 5177-5186
14. Yang T.F., Chen C.N., Chen M.C., Lai C.H., Liang H.F., and Sung H.W. Shell-crosslinked pluronic L121 micelles as a drug delivery vehicle. Biomaterials 28 (2007) 725-734
15. Rosner D., McCarthy N., and Bennett M. Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53. Cardiovasc Res 66 (2005) 601-610
16. Liang H.F., Chen S.C., Chen M.C., Lee P.W., Chen C.T., and Sung H.W. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells. Bioconjug Chem 17 (2006) 291-299
17. Chen M.C., Chang Y., Liu C.T., Lai W.Y., Peng S.F., Hung Y.W., et al. The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. Biomaterials 30 (2009) 79-88
18. Park K., Shalaby W.S.W., and Park H. Biodegradable hydrogels for drug delivery (1993), Technomic Publishers, Lancaster, PA p. 2
19. Kim D.H., and Martin D.C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27 (2006) 3031-3037
20. Defail A.J., Edington H.D., Matthews S., Lee W.C., and Marra K.G. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds. J Biomed Mater Res A 79 (2006) 954-962
21. Liu J., Zhang S.M., Chen P.P., Cheng L., Zhou W., Tang W.X., et al. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels. J Mater Sci Mater Med 18 (2007) 2208-2210
22. Liu L., Guo K., Lu J., Venkatraman S.S., Luo D., Ng K.C., et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 29 (2008) 1509-1517
23. Kwon G.S. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst 20 (2003) 357-403
24. Otsuka H., Nagasaki Y., and Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 55 (2003) 403-419
25. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73 (2001) 137-172
26. Torchilin V.P., Lukyanov A.N., Gao Z., and Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci U S A 100 (2003) 6039-6044
27. Liu H., Farrell S., and Uhrich K. Drug release characteristics of unimolecular polymeric micelles. J Control Release 68 (2000) 167-174
28. Ip J.H., Fuster V., Israel D., Badimon L., Badimon J., and Chesebro J.H. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 17 (1991) 77B-88B
29. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86 (1992) 723-729
30. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
31. Fukuda J., Khademhosseini A., Yeo Y., Yang X., Yeh J., Eng G., et al. Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials 27 (2006) 5259-5267
32. Suzuki T., Kopia G., Hayashi S., Bailey L.R., Llanos G., Wilensky R., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
33. Lüscher T.F., Steffel J., Eberli F.R., Joner M., Nakazawa G., Tanner F.C., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
34. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202